| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 265,359 | 265,359 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 154,879 | 141,725 |
| Net increase in cash, cash equivalents and restricted cash | 1,717,040 | -2,763,595 |
| Cash and cash equivalents at beginning of period | 3,796,379 | - |
| Cash and cash equivalents at end of period | 5,513,419 | - |
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)